Healthcare provider profile · identity verified

Ray Mark Martin, M.D.

Family Practice · BROWNWOOD, TX · NPI 1831197300

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	297	48
Levothyroxine Sodium	Levothyroxine Sodium	227	56
Metoprolol Succinate	Metoprolol Succinate	215	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	209	40
Gabapentin	Gabapentin	174	41
Amlodipine Besylate	Amlodipine Besylate	172	48
Zolpidem Tartrate	Zolpidem Tartrate	172	21
Tamsulosin Hcl	Tamsulosin Hcl	133	34
Omeprazole	Omeprazole	132	34
Tramadol Hcl	Tramadol Hcl	127	25
Azithromycin	Azithromycin	121	81
Duloxetine Hcl	Duloxetine Hcl	121	24
Rosuvastatin Calcium	Rosuvastatin Calcium	115	34
Atorvastatin Calcium	Atorvastatin Calcium	110	29
Losartan Potassium	Losartan Potassium	104	24
Potassium Chloride	Potassium Chloride	102	27
Trazodone Hcl	Trazodone Hcl	102	18
Clonazepam	Clonazepam	100	17
Ezetimibe	Ezetimibe	98	25
Metoprolol Tartrate	Metoprolol Tartrate	98	23
Acetaminophen-Codeine	Acetaminophen With Codeine	93	21
Furosemide	Furosemide	92	27
Temazepam	Temazepam	89	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	86	21
Meloxicam	Meloxicam	75	20
Lisinopril	Lisinopril	67	22
Lorazepam	Lorazepam	65	suppressed
Allopurinol	Allopurinol	64	15
Metformin Hcl	Metformin Hcl	62	15
Pantoprazole Sodium	Pantoprazole Sodium	60	21
Estradiol	Estradiol	56	11
Levofloxacin	Levofloxacin	55	41
Celecoxib	Celecoxib	54	16
Hydrochlorothiazide	Hydrochlorothiazide	53	13
Donepezil Hcl	Donepezil Hcl	52	11
Prednisone	Prednisone	51	35
Esomeprazole Magnesium	Esomeprazole Magnesium	49	11
Clopidogrel	Clopidogrel Bisulfate	48	suppressed
Pregabalin	Pregabalin	46	11
Diazepam	Diazepam	45	12
Ozempic	Semaglutide	44	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	43	12
Doxycycline Hyclate	Doxycycline Hyclate	43	24
Clonidine Hcl	Clonidine Hcl	42	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	42	11
Xarelto	Rivaroxaban	42	suppressed
Irbesartan	Irbesartan	41	suppressed
Spironolactone	Spironolactone	41	suppressed
Carvedilol	Carvedilol	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	28
Synthroid	Levothyroxine Sodium	40	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Methylprednisolone	Methylprednisolone	39	29
Montelukast Sodium	Montelukast Sodium	39	suppressed
Propranolol Hcl	Propranolol Hcl	39	11
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Eliquis	Apixaban	34	suppressed
Fluconazole	Fluconazole	34	20
Glimepiride	Glimepiride	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Glipizide	Glipizide	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	suppressed
Cephalexin	Cephalexin	27	17
Januvia	Sitagliptin Phosphate	25	suppressed
Atenolol	Atenolol	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Armodafinil	Armodafinil	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Jardiance	Empagliflozin	21	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Repatha Syringe	Evolocumab	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Simvastatin	Simvastatin	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	12
Eszopiclone	Eszopiclone	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Piroxicam	Piroxicam	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	14	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Digoxin	Digoxin	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	12
Valacyclovir	Valacyclovir Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	12
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Testosterone	Testosterone	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Carisoprodol	Carisoprodol	11	suppressed
Famotidine	Famotidine	11	suppressed
Linzess	Linaclotide	11	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error